Share Name Share Symbol Market Type Share ISIN Share Description
Eco Animal Health Group Plc LSE:EAH London Ordinary Share GB0032036807 ORD 5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.0% 205.00 200.00 210.00 205.00 205.00 205.00 6,379 08:00:00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 74.6 15.2 17.6 11.6 138

Eco Animal Health Share Discussion Threads

Showing 426 to 450 of 1100 messages
Chat Pages: Latest  20  19  18  17  16  15  14  13  12  11  10  9  Older
DateSubjectAuthorDiscuss
04/10/2013
15:08
money has been raised for VERY good reasons! Peter Lawrence has also bought more shares, and will now hold over 18% of EAH
smelleroo
04/10/2013
14:32
194p here we come!
audigger
03/10/2013
10:50
Blimey, I didn't see this coming! Explains the long slow drift of recent months. Clealry the underying business is doing well, so one has to hope this is a one-off. Arguably a good opportunity to add, but this is looking longer & longer term in terms of the pot of gold at the end of the rainbow. As previously noted on this board, it does make you wonder about the buisness model and the cut in margin taken along the distribution chain.
audigger
10/9/2013
20:34
Once the US market kicks-in then the future revenue & profit will increase significantly. I expect 2014-2015 revenue & profit to be a step-change from where we are today.
audigger
10/9/2013
00:40
I have reread the year end report and am again encouraged by their future prospects. all regions did well last year except s. America but apparently that came good in the last two months. what we need is for the chaimans encouraging remarks for the future to be turned in sustainable, growing revenues and profits.
cnx
09/9/2013
17:58
Yes, patience definitely needed here. I would like to see some better financial results pretty soon as well as they have been, quite frankly, a tad disappointing for far too long.
topvest
09/9/2013
17:24
I am expecting an upward movement back to 265 and even higher with corporate action.I firmly believe that the patient shareholder will be rewarded.
ltinvestor
05/9/2013
22:22
I am a long term holder since the Lawrence days and its clear that this is a very different business. Pet products to medicine for animals, that takes time licences, sales people new markets and stuff. I haven't lost any money and don't expect that I will.
david2013
05/9/2013
20:06
@ topvest: yeah, but since 2001 they're focused on the animal drug stuff and have now got ahead of where they were in 2005! I guess they may want to be in play?
eatlessbread
02/9/2013
13:31
The slide continues despite the fact its a very blue day for the FTSE. Must be a seller afoot! I really did expect these to start to push 300 following the FDA news so the drift has been a tad disappointing. I guess we'll need to wait until the US business starts to positively impactthe bottom line, then we should move-up sharply. Is next week also ex-divi date? We may see another small drop. More patience required!
audigger
28/7/2013
19:16
A sobering thought though... 2001 accounts £32m sales, £12m gross profit, £3.5m PBT wind-on 12 years... 2013 accounts £29m sales, £13m gross profit, £3.3m PBT So, it's taken 10 years + to get no sales or profit growth. Slow going indeed. Continued jam tomorrow, but the business is much more valuable than 12 years ago I suppose.
topvest
16/7/2013
01:01
as I understand it, every invention has to be registered in each jurisdiction they seek a patent. so, it is possible there will be various termination dates
cnx
15/7/2013
18:14
Yes, I agree. Sounds like the patent is for quite a long time, but it would be nice to know. It might be possible to find out in the patent register.
topvest
15/7/2013
07:50
Topvest, as I understand it the change from 10-20 years is just a change in accounting practice but one with a positive impact nevertheless. However, the interesting question this poses (and one I've raised before on this board but I don't recall an answer) is how long EAH have left on thier patent for Aivlosin. This is the major factor influencing the value they can extract from this molecule because once it becomes generic, then their margin will drop significantly. Interesting that there is no mention of the anti-viral research. I'd like to know where things are at with this even though its very speculative.
audigger
13/7/2013
11:54
My understanding is that third party distributors take about a 50% margin. A bigger company, operating internationally and with it's own sales forces could improve EAH's profits nearly three fold. Full value for the company is probably around 600p so patience is called for.
aimingupward2
13/7/2013
11:30
The true value of Aivlosin is far greater than the present market cap which will be realised on further US registrations and subsequent sales. I am expecting corporate news in the next 6 months.
ltinvestor
13/7/2013
10:13
topvest Doubt it will be acquired it's already expensive so with the usual markup at least 30% and the current earnings i think it would be considerably overpriced but you never know there's always someone! Woody
woodcutter
13/7/2013
07:06
Yes, results are still quite skewed by drug registration and set-up costs. This is a very high quality business though and has the potential for long term growth over a long time period. The results for last year were positively impact by a change in the life of drug registration intangibles from 10 to 20 years which improved profits by £1.3m. It has been a bit of a "jam tomorrow" stock, but things are progressing in the right direction. There is still significant upside if the Group is acquired by a major with their own distribution network.
topvest
12/7/2013
11:20
Woody : > Good points - You ahve confirmed my doubts - Well done with ANP - Had dropped off my radar screen wwhen was Kirotech. Looks imprssive .
pugugly
12/7/2013
09:03
Can't argue that the results are impressive and all the financials seem strong , P&L BS and CFlow, but the valuation looks a bit steep, compared to others in the sector, particularly ANP one of my core holdings. Can't see that there's much margin for error so on a risk reward i'm a little concerned to enter now. Looked at it several times a few years ago when it was below 140p, looked expensive then too so wtfdik! Price earnings ratios figs from DLook: (hard to be sure if these are fair comparisons but the ANP disparity does look wide) ANP 12.4 DPH 21.6 EAH 51.7 GNS 26.2 I think ANP are playing a bit of catch up too. Anyone seen any forecasts for this forth coming year. Woody
woodcutter
12/7/2013
07:25
Agreed results look promising but pe still very high. Post tax eps of 4.9 leaves on a trailing p/e ratio of some 49 - very much jam tomorrow.[ I think this p/e is correct but could someone double check) The house broker Cenkos should be hanging their head in shame as they were forcasting eps of 10.4p and a dividend of 4.3p Missed on both. For debate how far off 2014 results will they be ? Their previous forecast (Refs May) was for pretax of £9 million and eps of 13.2p - (imo) now unlikely to be met uless very significant increase in revenue and margins. Thoughts ??
pugugly
12/7/2013
06:59
Topvest, Question which you allude to, is how does EAH get to the next level? I cannot help feel that it will NOT be just an organic story here, the momentum in the business is very good currently and will NOT go unnoticed. This area is becoming more and more important as it enters our foodchain! smell
smelleroo
12/7/2013
06:54
Yes, very pleased with results especially increasing margins and the prospect of further US registrations.Slow burner that will eventually be taken out at a very nice premium imo.
ltinvestor
12/7/2013
06:53
All looks very promising. I suspect this may now attract some higher profile write-ups and broaden interest which should be good for the share price Wouldn't like to predict the share price move today. In theory it should have no problem heading back to 280 in the short-term, but this is an AIM share and anything is possible!
audigger
12/7/2013
06:36
Results out today - they look pretty good and the outlook is very promising with improving margins and significant turnover growth. Still investing lots in product development, but still able to self finance this. 4p dividend is an acceptable return until we wait for this business to really reach it's peak - how long will that take I wonder?
topvest
Chat Pages: Latest  20  19  18  17  16  15  14  13  12  11  10  9  Older
Your Recent History
LSE
EAH
Eco Animal..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20191208 18:17:30